NICOLE GOBEN: Open Payments
NPI 1194470518 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 35 payments from 8 companies in 2025. Trend: 2023 $77 · 2024 $493 · 2025 $761
Food & beverage: $704Education: $57
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $215 |
| Regeneron Healthcare Solutions, Inc. | 7 | $211 |
| GlaxoSmithKline, LLC. | 9 | $150 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
| Optinose US, Inc. | 2 | $55 |
| ABBVIE INC. | 2 | $44 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Phadia US Inc. | 1 | $14 |
Products named: DUPIXENT, NUCALA, Xhance, VRAYLAR, ImmunoCAP.
Industry payments across NV — which companies pay providers there.
